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General Information: Unless otherwise noted, all commercial materials were used without further 
purification. Anhydrous solvents obtained from Aladdin and Adamas were used directly without 
further purification, and solvents obtained from other commercial suppliers were used after 
purification as specified in Purification of Laboratory Chemicals, 6th Ed. Optical rotations were 
measured on a Perkin-Elmer 241 polarimeter equipped with a Na-lamp. HPLC analyses were 
performed on a Shimadzu SPD-20A. Nuclear magnetic resonance (NMR) spectra were recorded with 
a Bruker AVANCE 400MHz instrument. 1H and 13C chemical shifts are reported in ppm downfield of 
tetramethylsilane and referenced to residual solvent peak (CHCl3 = 7.26 (1H NMR), DMSO = 2.50 
(1H NMR), CDCl3 = 77.16 (13C NMR)) unless otherwise noted. Multiplicities are reported using the 
following abbreviations: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad 
resonance. High-resolution mass spectra for new compounds were recorded at Mass Spectrometry 
Facilities, Zhejiang University. X-ray diffraction experiments were performed at X-Ray Facilities, 
Zhejiang University. 
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Experimental Procedures: 
Preparation of Lactic Acid Substrates 
(S)-2-Methoxy-N-(quinolin-8-yl)propanamide (1a) 
 
To a stirred solution of (S)-2-methoxypropanoic acid 1 (10.41 g, 100 mmol) in dry dichloromethane 
(300 mL), 4-methylmorpholine (NMM, 11.5 mL, 105 mmol) was added slowly at 0 °C. After the 
solution was stirred for five minutes, iso-butyl carbonochloridate (13.3 mL, 105 mmol) was added 
dropwise slowly at 0 °C. The mixture was then stirred at room temperature for 1.5 h. A solution of 
8-aminoquinoline (8.65 g, 60 mmol) in dry dichloromethane (50 mL) was slowly added to the reaction 
at 0 °C. After the reaction was stirred at room temperature overnight, the resulting mixture was then 
washed by aqueous HCl (100 mL, 0.1 M), saturated Na2CO3 (100 mL), brine (100 mL), and dried over 
anhydrous MgSO4. Evaporation of organic solvent and purification by silica gel column 
chromatography in 6:3:1 petroleum ether: dichloromethane: ethyl acetate, afforded the pure 
8-aminoquinoline amide 1a (13.12 g, 95%) as a white solid. [α]D20 = -66.3 (CHCl3, c=1.0). HPLC 
Chiralpak® AD-H column, n-hexane/isopropanol = 95: 5, flow rate = 1.00 mL/min, λ = 254 nm, 
11.3 (minor), 12.1 (major), 97% ee. 1H NMR (400 MHz, CDCl3) δ 10.80 (s, 1H), 8.86 (dd, J = 4.0, 1.6 
Hz, 1H), 8.80 (dd, J = 6.4, 2.4 Hz, 1H), 8.16 (dd, J = 8.4, 1.6 Hz, 1H), 7.57 – 7.52 (m, 2H), 7.46 (dd, J 
= 8.4, 4.4 Hz, 1H), 3.99 (q, J = 6.8 Hz, 1H), 3.58 (s, 3H), 1.55 (d, J = 6.8 Hz, 3H); 13C NMR (101 MHz, 
CDCl3) δ 170.89, 148.63, 138.92, 137.77, 136.20, 133.95, 129.51, 128.38, 128.03, 127.27, 126.60, 
122.06, 121.69, 116.63, 84.55, 59.32, 39.58; HRMS (EI) m/z: 230.1058(M+), calc. for C13H14N2O2: 
230.1055. 
Chiral HPLC Data  
HPLC Conditions  
Chiral Stationary phase: Chiralpak® AD-H, n-hexane/isopropanol = 95:5, 1.00 mL/min  
Signal: VWD1 A, Wavelength = 254 nm 
rac-1a  
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L-1a 
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(S)-2-Benzyloxy-N-(quinolin-8-yl)propanamide (1b) 
O HN
O
N
 
The preparation of 1b followed the same procedure of 1a except using (S)-2-benzyloxypropanoic 
acid instead of (S)-2-methoxypropanoic acid. The compound 1b was obtained as a light yellow solid. 
1H NMR (400 MHz, CDCl3) δ 11.09 (s, 1H), 9.16 – 8.69 (m, 2H), 8.15 (dd, J = 8.2, 1.3 Hz, 1H), 
7.79 – 7.51 (m, 4H), 7.51 – 7.27 (m, 4H), 4.80 (d, J = 11.3 Hz, 1H), 4.70 (d, J = 11.3 Hz, 1H), 4.22 
(qd, J = 6.7, 6.7, 0.8 Hz, 1H), 1.62 (d, J = 6.6 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 172.04, 
148.47, 138.98, 137.43, 136.23, 134.18, 128.56, 128.16, 128.07, 127.34, 121.93, 121.72, 116.54, 
77.13, 72.47, 18.92; HRMS (EI) m/z: 306.1369(M+), calcd. for C19H18N2O2: 306.1368. 
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Optimization of Reaction Conditions for Mono-alkylation of 1a 
(1) Optimization of Silver Salts (KOCN and t-AmylOH used as Base and Solvent)  
 
Entry Ag(I) salt Yield 3a RSM 
1 Ag2CO3 34% 59% 
2 AgF <2% >80% 
3 AgOAc <2% >80% 
4 AgOPiv ~3% >80% 
5 Ag2O 22% 71% 
6 Ag3PO4 <2% >80% 
7 AgOCN ~3% >80% 
8 Ag2SO4 <1% >80% 
9 AgSCN <1% >80% 
10 / 0 >90% 
Reaction conditions: 1a (0.20 mmol, 1.0 eq), 2a (0.40 mmol, 2.0 eq), Pd(OAc)2 (0.02 mmol, 10 
mol%), Ag(I) salt (0.40 mmol, 2.0 eq), KOCN (0.40 mmol, 2.0 eq), t-AmylOH (2.0 ml), reaction for 
20 hours at 90 °C and under N2 atmosphere. 
(2) Optimization of Solvent (KOCN and Ag2CO3 used as Base and Silver Salt) 
 
Entry Solvent Yield 3a RSM 
1 tAmylOH 34% 59% 
2 tBuOH 49% 33% 
3 iPrOH 0 >90% 
4 DMF 0 >80% 
5 THF <5% >80% 
6 2-Me-THF <10% >70% 
7 Acetone ~10% >70% 
8 DME ~10% >80% 
9 AcOEt 22% 72% 
10 CF3CO2Et 0 >90% 
11 HFIP 0 >80% 
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12 PhMe ~2% >80% 
13 1,4-dioxane ~2% >80% 
14 MeCN 0 >80% 
15 tBuCN 0 >80% 
Reaction conditions: 1a (0.20 mmol, 1.0 eq), 2a (0.40 mmol, 2.0 eq), Pd(OAc)2 (0.02 mmol, 10 
mol%), Ag2CO3 (0.40 mmol, 2.0 eq), KOCN (0.40 mmol, 2.0 eq), solvent (2.0 ml), reaction for 20 
hours at 90 °C and under N2 atmosphere. 
(3) Optimization of Base (t-BuOH and Ag2CO3 used as Solvent and Silver Salt) 
 
Entry Base Yield 3a RSM 
1 / ~3% >80% 
2 KOCN 49% 33% 
3 K2CO3 61% (62%) 22% 
4 K3PO4 58% 27% 
5 KF 43% 51% 
6 KOAc 50% 44% 
7 MesCO2K 49% 43% 
8 KTFA 45% 37% 
9 Li2CO3 ~3% >80% 
10 Li3PO4 ~5% >80% 
11 LiOAc ~2% >80% 
12 Na2CO3 33% 55% 
13 Na3PO4 29% 55% 
14 NaOAc 20% 64% 
15 Cs2CO3 35% 54% 
16 CsOAc 45% 46% 
17 Rb2CO3 61% 24% 
18 RbOAc 53% 38% 
19 K2CO3 (1.0 eq) 61% (62%) 21% 
19 K2CO3 (0.5 eq) 58% 27% 
20 K2CO3 (0.2 eq) 53% 33% 
21 K3PO4 (0.2 eq) 32% 47% 
22 KOAc (0.2 eq) 51% 38% 
23 Rb2CO3 (0.2 eq) 55% 32% 
24 b K2CO3 (1.0 eq) 63% (64%) 21% 
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Reaction conditions: 1a (0.20 mmol, 1.0 eq), 2a (0.40 mmol, 2.0 eq), Pd(OAc)2 (0.02 mmol, 10 
mol%), Ag2CO3 (0.40 mmol, 2.0 eq), base (0.40 mmol, 2.0 eq), t-BuOH (2.0 ml), reaction for 20 hours 
at 90 °C and under N2 atmosphere; a 100 °C; b Isolated yields indicated in the parentheses. 
(S)-2-Methoxy-N-(quinolin-8-yl)heptanamide (3a) 
 
The title compound was prepared under the optimized condition. The crude product was purified by 
silica gel column chromatography in 12:2:1 petroleum ether: dichloromethane: ethyl acetate, 
providing 3a as a colorless oil (36.9 mg, 64%) with 1a (9.9 mg, 21%) recovered. [α]D20 = -50.0 
(CHCl3, c=1.0). HPLC Chiralpak® AD-H column, n-hexane/isopropanol = 95: 5, flow rate = 1.00 
mL/min, λ = 254 nm, 9.0 (minor), 12.5 (major), 94% ee.1H NMR (400 MHz, CDCl3) δ 10.79 (s, 1H), 
8.85 (dd, J = 4.2, 1.6 Hz, 1H), 8.81 (dd, J = 6.7, 2.1 Hz, 1H), 8.15 (dd, J = 8.3, 1.5 Hz, 1H), 7.59 – 7.49 
(m, 2H), 7.44 (dd, J = 8.3, 4.2 Hz, 1H), 3.84 (dd, J = 7.3, 4.4 Hz, 1H), 3.57 (s, 3H), 1.99 – 1.78 (m, 2H), 
1.57 – 1.45 (m, 2H), 1.38 – 1.29 (m, 4H), 0.88 (t, J = 7.0 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 
171.89, 148.70, 139.06, 136.28, 134.18, 128.14, 127.37, 121.94, 121.72, 116.65, 83.70, 58.85, 33.22, 
31.79, 24.89, 22.63, 14.14; HRMS (EI) m/z: 286.1680 (M+), calc. for C17H22N2O2: 286.1681. 
 
Chiral HPLC Data  
HPLC Conditions  
Chiral Stationary phase: Chiralpak® AD-H, n-hexane/isopropanol = 95:5, 1.00 mL/min  
Signal: VWD1 A, Wavelength = 254 nm 
Rac-3a 
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L-3a 
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General Procedure (GP) for Mono-alkylation of Lactic Acid Derivative 
To a 30-mL resealable Schlenk flask were added 1a (46.1 mg, 0.2 mmol), Pd(OAc)2 (4.5 mg, 0.02 
mmol), alkyl iodide (0.4 mmol), Ag2CO3 (110.3 mg, 0.4 mmol), K2CO3 (27.6 mg, 0.2 mmol), and 
t-BuOH (2.0 mL). The Schlenk flask was charged with 1 atm of N2. The mixture was stirred at 
100 °C for 20 hours (for deuterated alkyl iodides, the reactions were run at 90 °C). The reaction 
vessel was allowed to cool to room temperature, and dichloromethane (5 mL) was added. The 
resulting mixture was filtered through a pad of Celite, which was subsequently washed with 
additional dichloromethane (20 mL). Evaporation of the organic solvent and purification by silica gel 
column chromatography gave the corresponding product. 
Scope of alkyl iodides: 
 
(S)-2-Methoxy-N-(quinolin-8-yl)butanamide (3b) 
O HN
O
N
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The title compound was prepared according to the GP. The crude product was purified by silica gel 
column chromatography in 12:2:1 petroleum ether: dichloromethane: ethyl acetate, providing 3b as 
a white solid (33.4 mg, 68%) [α]D20 = -88.2 (CHCl3, c = 0.75), with 3b’ (10.2 mg, 20%) isolated. 1H 
NMR (400 MHz, CDCl3) δ 10.79 (s, 1H), 8.85 (dd, J = 4.2, 1.6 Hz, 1H), 8.82 (dd, J = 6.8, 1.9 Hz, 
1H), 8.14 (d, J = 8.2 Hz, 1H), 7.64 – 7.48 (m, 2H), 7.44 (dd, J = 8.2, 4.2 Hz, 1H), 3.82 (dd, J = 6.5, 
4.5 Hz, 1H), 3.58 (s, 3H), 2.07 – 1.82 (m, 2H), 1.04 (d, J = 7.4 Hz, 3H); 13C NMR (101 MHz, 
CDCl3) δ 171.60, 148.69, 139.05, 136.27, 134.15, 128.13, 127.35, 121.94, 121.71, 116.64, 84.46, 
58.73, 26.07, 9.40; HRMS (EI) m/z: 244.1215 (M+); calc. for C14H16N2O2: 244.1212. 
(S)-2-Methoxy-3-methyl-N-(quinolin-8-yl)butanamide (3b’) 
O HN
O
N
 
1H NMR (400 MHz, CDCl3) δ 10.75 (s, 1H), 8.86 (d, J = 4.1 Hz, 1H), 8.82 (dd, J = 6.7, 1.9 Hz, 1H), 
8.16 (d, J = 8.2 Hz, 1H), 7.60 – 7.48 (m, 2H), 7.45 (dd, J = 8.2, 4.2 Hz, 1H), 3.63 (d, J = 4.4 Hz, 1H), 
3.59 (s, 3H), 2.31 – 2.18 (m, 1H), 1.10 (d, J = 6.9 Hz, 3H), 1.02 (d, J = 6.8 Hz, 3H); 13C NMR (101 
MHz, CDCl3) δ 171.38, 148.74, 139.11, 136.28, 134.13, 128.17, 127.40, 121.92, 121.74, 116.65, 
88.67, 59.84, 32.12, 19.20, 17.34; HRMS (EI) m/z: 258.1369 (M+); calc. for C15H18N2O2: 258.1368. 
(S)-2-Methoxy-N-(quinolin-8-yl)pentanamide (3c) 
 
The title compound was prepared according to the GP. The crude product was purified by silica gel 
column chromatography in 12:2:1 petroleum ether: dichloromethane: ethyl acetate, providing 3c as a 
colorless oil (30.3 mg, 59%). [α]D20 = -104.2 (CHCl3, c = 1.0). 1H NMR (400 MHz, CDCl3) δ 10.79 
(s, 1H), 8.85 (dd, J = 4.2, 1.6 Hz, 1H), 8.81 (dd, J = 6.8, 1.9 Hz, 1H), 8.14 (dd, J = 8.2, 1.4 Hz, 1H), 
7.59 – 7.50 (m, 2H), 7.44 (dd, J = 8.2, 4.2 Hz, 1H), 3.86 (dd, J = 7.1, 4.6 Hz, 1H), 3.57 (s, 3H), 1.98 
– 1.78 (m, 2H), 1.53 (dq, J = 14.9, 7.4 Hz, 2H), 0.96 (t, J = 7.4 Hz, 3H); 13C NMR (101 MHz, 
CDCl3) δ 171.89, 148.69, 139.04, 136.27, 134.16, 128.13, 127.36, 121.93, 121.72, 116.63, 83.48, 
58.85, 35.30, 18.51, 14.01; HRMS (EI) m/z: 258.1366 (M+); calc. for C15H18N2O2: 258.1368. 
(S)-2-Methoxy-N-(quinolin-8-yl)hexanamide (3d) 
 
The title compound was prepared according to the GP. The crude product was purified by silica gel 
column chromatography in 12:2:1 petroleum ether: dichloromethane: ethyl acetate, providing 3d as 
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a colorless oil (32.4 mg, 59%).[α]D20 = -94.6 (CHCl3, c = 0.5). 1H NMR (400 MHz, CDCl3) δ 10.79 
(s, 1H), 8.85 (dd, J = 4.2, 1.6 Hz, 1H), 8.81 (dd, J = 6.8, 1.7 Hz, 1H), 8.14 (d, J = 8.2 Hz, 1H), 7.61 
– 7.49 (m, 2H), 7.44 (dd, J = 8.2, 4.2 Hz, 1H), 3.85 (dd, J = 7.1, 4.5 Hz, 1H), 3.57 (s, 3H), 2.00 – 
1.78 (m, 2H), 1.48 (dt, J = 15.4, 7.5 Hz, 2H), 1.42 – 1.31 (m, 2H), 0.90 (t, J = 7.2 Hz, 3H); 13C 
NMR (101 MHz, CDCl3) δ 171.87, 148.69, 139.05, 136.26, 134.17, 128.13, 127.36, 121.93, 121.71, 
116.63, 83.66, 58.83, 32.94, 27.32, 22.68, 14.06; HRMS (EI) m/z: 272.1529 (M+); calc. for 
C16H20N2O2: 272.1525. 
(S)-2-Methoxy-N-(quinolin-8-yl)nonanamide (3e) 
 
The title compound was prepared according to the GP. The crude product was purified by silica gel 
column chromatography in 14:2:1 petroleum ether: dichloromethane: ethyl acetate, providing 3e as a 
colorless oil (39.9 mg, 63%).[α]D20 = -68.0 (CHCl3, c = 1.0). 1H NMR (400 MHz, CDCl3) δ 10.79 (s, 
1H), 8.85 (dd, J = 4.0, 1.3 Hz, 1H), 8.82 (dd, J = 6.8, 1.7 Hz, 1H), 8.15 (dd, J = 8.2, 1.3 Hz, 1H), 
7.62 – 7.49 (m, 2H), 7.44 (dd, J = 8.2, 4.2 Hz, 1H), 3.85 (dd, J = 7.2, 4.4 Hz, 1H), 3.58 (s, 3H), 2.00 
– 1.77 (m, 2H), 1.57 – 1.44 (m, 2H), 1.36 – 1.23 (m, 8H), 0.86 (t, J = 6.5 Hz, 3H); 13C NMR (101 
MHz, CDCl3) δ 171.88, 148.68, 139.05, 136.26, 134.18, 128.13, 127.37, 121.92, 121.71, 116.64, 
83.69, 58.84, 33.26, 31.90, 29.56, 29.26, 25.21, 22.73, 14.18; HRMS (EI) m/z: 314.1997 (M +); calc. 
for C19H26N2O2: 314.1994. 
(S)-2-Methoxy-N-(quinolin-8-yl)undecanamide (3f) 
 
The title compound was prepared according to the GP. The crude product was purified by silica gel 
column chromatography in 15:2:1 petroleum ether: dichloromethane: ethyl acetate, providing 3f as a 
colorless oil (41.7 mg, 61%). [α]D20 = -55.0 (CHCl3, c = 1.0). 1H NMR (400 MHz, CDCl3) δ 10.79 (s, 
1H), 8.85 (dd, J = 4.0, 1.4 Hz, 1H), 8.81 (dd, J = 6.8, 1.9 Hz, 1H), 8.15 (dd, J = 8.1, 1.2 Hz, 1H), 7.61 
– 7.48 (m, 2H), 7.44 (dd, J = 8.2, 4.2 Hz, 1H), 3.84 (dd, J = 7.2, 4.4 Hz, 1H), 3.57 (s, 3H), 1.99 – 1.77 
(m, 2H), 1.56 – 1.44 (m, 2H), 1.27 (s, 12H), 0.86 (t, J = 6.7 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 
171.88, 148.69, 139.06, 136.27, 134.19, 128.14, 127.38, 121.92, 121.72, 116.65, 83.70, 58.85, 33.27, 
31.99, 29.65, 29.60, 29.40, 25.21, 22.78, 14.22; HRMS (EI) m/z: 342.2306 (M+); calc. for C21H30N2O2: 
342.2307. 
(S)-2-Methoxy-N-(quinolin-8-yl)henicosanamide (3g) 
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The title compound was prepared according to the GP. The crude product was purified by silica gel 
column chromatography in 20:2:1 petroleum ether: dichloromethane: ethyl acetate, providing 3g as a 
white solid (58.4 mg, 61%). [α]D20 = -47.4 (CHCl3, c = 1.2). 1H NMR (400 MHz, CDCl3) δ 10.79 (s, 
1H), 8.85 (dd, J = 4.0, 1.1 Hz, 1H), 8.82 (dd, J = 6.8, 1.6 Hz, 1H), 8.14 (dd, J = 8.2, 1.3 Hz, 1H), 7.61 
– 7.47 (m, 2H), 7.44 (dd, J = 8.2, 4.2 Hz, 1H), 3.85 (dd, J = 7.2, 4.4 Hz, 1H), 3.57 (s, 3H), 2.00 – 1.78 
(m, 2H), 1.54 – 1.44 (m, 2H), 1.25 (s, 32H), 0.88 (t, J = 6.7 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 
171.87, 148.67, 139.06, 136.25, 134.19, 128.13, 127.37, 121.91, 121.70, 116.65, 83.70, 58.83, 33.27, 
32.05, 29.83, 29.79, 29.76, 29.72, 29.61, 29.49, 25.22, 22.82, 14.24; HRMS (EI) m/z: 482.3876 (M+); 
calc. for C31H50N2O2: 482.3872. 
(S)-5-Cyclohexyl-2-methoxy-N-(quinolin-8-yl)pentanamide (3h) 
 
The title compound was prepared according to the GP. The crude product was purified by silica gel 
column chromatography in 15:2:1 petroleum ether: dichloromethane: ethyl acetate, providing 3h as a 
colorless oil (40.3 mg, 59%). [α]D20 = -68.9 (CHCl3, c = 1.2). 1H NMR (400 MHz, CDCl3) δ 10.78 (s, 
1H), 8.85 (dd, J = 4.2, 1.6 Hz, 1H), 8.81 (dd, J = 6.8, 2.0 Hz, 1H), 8.14 (dd, J = 8.3, 1.6 Hz, 1H), 7.62 
– 7.48 (m, 2H), 7.44 (dd, J = 8.3, 4.2 Hz, 1H), 3.84 (dd, J = 7.3, 4.4 Hz, 1H), 3.57 (s, 3H), 1.94 – 1.76 
(m, 2H), 1.72 – 1.58 (m, 5H), 1.56 – 1.46 (m, 2H), 1.28 – 1.11 (m, 6H), 0.91 – 0.79 (m, 2H); 13C NMR 
(101 MHz, CDCl3) δ 171.88, 148.67, 139.05, 136.26, 134.17, 128.12, 127.36, 121.91, 121.70, 116.64, 
83.72, 58.87, 37.61, 37.38, 33.58, 33.50, 33.45, 26.81, 26.50, 22.53; HRMS (EI) m/z: 340.2151 (M+); 
calc. for C21H28N2O2: 340.2151. 
(S)-2-Methoxy-6-phenyl-N-(quinolin-8-yl)hexanamide (3i) 
 
The title compound was prepared according to the GP. The crude product was purified by silica gel 
column chromatography in 10:2:1 petroleum ether: dichloromethane: ethyl acetate, providing 3i as a 
colorless oil (43.3 mg, 62%). [α]D20 = -65.2 (CHCl3, c = 1.0). 1H NMR (400 MHz, CDCl3) δ 10.79 (s, 
1H), 8.85 (dd, J = 4.3, 1.5 Hz, 1H), 8.81 (d, J = 6.8 Hz, 1H), 8.14 (d, J = 8.3 Hz, 1H), 7.58 – 7.48 (m, 
2H), 7.44 (dd, J = 8.2, 4.2 Hz, 1H), 7.27 – 7.19 (m, 2H), 7.18 – 7.10 (m, 3H), 3.85 (dd, J = 6.7, 4.6 
Hz, 1H), 3.56 (s, 3H), 2.61 (t, J = 7.6 Hz, 2H), 2.02 – 1.83 (m, 2H), 1.71 – 1.62 (m, 2H), 1.60 – 1.51 
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(m, 2H); 13C NMR (101 MHz, CDCl3) δ 171.73, 148.69, 142.62, 139.04, 136.27, 134.12, 128.47, 
128.35, 128.12, 127.35, 125.73, 121.96, 121.72, 116.65, 83.54, 58.85, 35.89, 33.03, 31.45, 24.94; 
HRMS (EI) m/z: 348.1835 (M+); calc. for C22H24N2O2: 348.1838. 
(S)-7,7,7-Trifluoro-2-methoxy-N-(quinolin-8-yl)heptanamide (3j) 
 
The title compound was prepared according to the GP. The crude product was purified by silica gel 
column chromatography in 12:2:1 petroleum ether: dichloromethane: ethyl acetate, providing 3j as a 
colorless oil (37.9 mg, 56%). [α]D20 = -88.5 (CHCl3, c = 0.5). 1H NMR (400 MHz, CDCl3) δ 10.80 (s, 
1H), 8.86 (dd, J = 4.1, 1.5 Hz, 1H), 8.80 (dd, J = 6.1, 2.8 Hz, 1H), 8.16 (dd, J = 8.3, 1.5 Hz, 1H), 
7.61 – 7.49 (m, 2H), 7.46 (dd, J = 8.2, 4.2 Hz, 1H), 3.86 (dd, J = 6.8, 4.6 Hz, 1H), 3.59 (s, 3H), 2.16 
– 1.99 (m, 2H), 1.99 – 1.82 (m, 2H), 1.66 – 1.52 (m, 4H); 13C NMR (101 MHz, CDCl3) δ 171.34, 
148.76, 139.04, 136.33, 134.02, 131.38, 128.63, 125.88, 123.14 (q, JC-F = 277.4 Hz), 128.16, 127.36, 
122.11, 121.78, 116.70, 83.18, 58.90, 34.17, 33.88, 33.60, 33.32 (q, JC-F = 28.6 Hz), 32.59, 24.32, 
21.93, 21.90, 21.87, 21.85 (q, JC-F = 2.8 Hz); HRMS (EI) m/z: 340.1401 (M+); calc. for 
C17H19F3N2O2: 340.1399. 
(S)-8-Chloro-2-methoxy-N-(quinolin-8-yl)octanamide (3k) 
 
The title compound was prepared according to the GP. The crude product was purified by silica gel 
column chromatography in 12:2:1 petroleum ether: dichloromethane: ethyl acetate, providing 3k as a 
colorless oil (39.7 mg, 59%). [α]D20 = -61.1 (CHCl3, c = 1.08). 1H NMR (400 MHz, CDCl3) δ 10.79 (s, 
1H), 8.85 (dd, J = 4.1, 1.6 Hz, 1H), 8.80 (dd, J = 6.5, 2.3 Hz, 1H), 8.15 (dd, J = 8.3, 1.6 Hz, 1H), 7.64 
– 7.47 (m, 2H), 7.44 (dd, J = 8.2, 4.2 Hz, 1H), 3.85 (dd, J = 7.1, 4.5 Hz, 1H), 3.57 (s, 3H), 3.50 (t, J = 
6.7 Hz, 2H), 1.98 – 1.80 (m, 2H), 1.79 – 1.70 (m, 2H), 1.56 – 1.47 (m, 2H), 1.46 – 1.32 (m, 4H); 13C 
NMR (101 MHz, CDCl3) δ 171.68, 148.70, 139.02, 136.27, 134.09, 128.12, 127.34, 121.98, 121.73, 
116.63, 83.50, 58.84, 45.14, 33.01, 32.61, 28.81, 26.82, 24.96; HRMS (EI) m/z: 334.1449 (M+); calc. 
for C18H23ClN2O2: 334.1448. 
(S)-Methyl 7-methoxy-8-oxo-8-(quinolin-8-ylamino)octanoate (3l) 
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The title compound was prepared according to the GP. The crude product was purified by silica gel 
column chromatography in 6:2:1 petroleum ether: dichloromethane: ethyl acetate, providing 3l as a 
colorless oil (39.5 mg, 57%). 1H NMR (400 MHz, CDCl3) δ 10.77 (s, 1H), 8.84 (dd, J = 4.1, 1.6 Hz, 
1H), 8.79 (dd, J = 6.5, 2.4 Hz, 1H), 8.14 (dd, J = 8.3, 1.6 Hz, 1H), 7.61 – 7.46 (m, 2H), 7.43 (dd, J = 
8.2, 4.2 Hz, 1H), 3.83 (dd, J = 7.1, 4.5 Hz, 1H), 3.63 (s, 3H), 3.56 (s, 3H), 2.28 (t, J = 7.5 Hz, 2H), 1.97 
– 1.78 (m, 2H), 1.62 (dt, J = 15.1, 7.5 Hz, 2H), 1.55 – 1.45 (m, 2H), 1.41 – 1.31 (m, 2H); 13C NMR 
(101 MHz, CDCl3) δ 174.20, 171.63, 148.68, 138.99, 136.25, 134.07, 128.10, 127.31, 121.96, 121.70, 
116.61, 83.44, 58.82, 51.51, 34.06, 32.91, 29.03, 24.87, 24.77; HRMS (EI) m/z: 344.1740 (M+); calc. 
for C19H24N2O4: 344.1736. 
(S)-Benzyl (7-methoxy-8-oxo-8-(quinolin-8-ylamino)octyl)carbamate (3m) 
 
The title compound was prepared according to the GP. The crude product was purified by silica gel 
column chromatography in 5:4:1 petroleum ether: dichloromethane: ethyl acetate, providing 3m as a 
white solid (54.1 mg, 60%). 1H NMR (400 MHz, CDCl3) δ 10.79 (s, 1H), 8.85 (dd, J = 3.9, 1.4 Hz, 
1H), 8.80 (dd, J = 6.3, 2.4 Hz, 1H), 8.15 (dd, J = 8.2, 1.4 Hz, 1H), 7.58 – 7.50 (m, 2H), 7.44 (dd, J = 
8.2, 4.2 Hz, 1H), 7.40 – 7.26 (m, 5H), 5.08 (s, 2H), 4.78 (s, 1H), 3.84 (dd, J = 6.9, 4.5 Hz, 1H), 3.57 (s, 
3H), 3.16 (q, J = 6.3 Hz, 2H), 1.96 – 1.80 (m, 2H), 1.56 – 1.43 (m, 4H), 1.39 – 1.28 (m, 4H); 13C NMR 
(101 MHz, CDCl3) δ 171.73, 156.48, 148.70, 139.02, 136.80, 136.27, 134.09, 128.59, 128.18, 128.13, 
127.34, 121.97, 121.72, 116.63, 83.50, 66.63, 58.82, 41.13, 33.00, 29.95, 29.16, 26.64, 25.00; HRMS 
(ESI) m/z: 449.2309 (M+); calc. for C26H31N3O4: 449.2315. 
(S)-6-((tert-Butyldiphenylsilyl)oxy)-2-methoxy-N-(quinolin-8-yl)hexanamide (3n) 
 
The title compound was prepared according to the GP. The crude product was purified by silica gel 
column chromatography in 15:2:1 petroleum ether: dichloromethane: ethyl acetate, providing 3n as 
a colorless oil (67.2 mg, 64%). [α]D20 = -49.0 (CHCl3, c = 0.9). 1H NMR (400 MHz, CDCl3) δ 10.83 
(s, 1H), 9.10 – 8.63 (m, 2H), 8.15 (dd, J = 8.4, 1.3 Hz, 1H), 7.79 – 7.63 (m, 4H), 7.59 – 7.51 (m, 2H), 
7.49 – 7.31 (m, 7H), 3.87 (dd, J = 6.2, 4.6 Hz, 1H), 3.69 (t, J = 5.8 Hz, 2H), 3.59 (s, 3H), 2.01 – 1.81 
(m, 2H), 1.74 – 1.54 (m, 4H), 1.04 (s, 9H); 13C NMR (101 MHz, CDCl3) δ 171.72, 148.66, 139.02, 
136.23, 135.66, 134.15, 134.12, 129.58, 128.10, 127.68, 127.34, 121.92, 121.69, 116.64, 83.55, 
63.82, 58.82, 32.98, 32.50, 26.95, 21.56, 19.28; HRMS (ESI) m/z: 526.2653 (M+); calc. for 
C32H38N2O3Si: 526.2652. 
(S)-10-Cyano-2-methoxy-10,10-diphenyl-N-(quinolin-8-yl)decanamide (3o) 
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The title compound was prepared according to the GP. The crude product was purified by silica gel 
column chromatography in 20:3:1 petroleum ether: dichloromethane: acetone, providing 3o as a 
colorless oil (35.5 mg, 35%). [α]D20 = -51.3 (CHCl3, c = 1.08). 1H NMR (400 MHz, CDCl3) δ 10.78 
(s, 1H), 8.85 (dd, J = 4.1, 1.5 Hz, 1H), 8.81 (dd, J = 6.5, 2.2 Hz, 1H), 8.15 (dd, J = 8.3, 1.6 Hz, 1H), 
7.59 – 7.50 (m, 2H), 7.45 (dd, J = 8.2, 4.2 Hz, 1H), 7.40 – 7.26 (m, 10H), 3.83 (dd, J = 7.0, 4.5 Hz, 
1H), 3.57 (s, 3H), 2.41 – 2.27 (m, 2H), 1.95 – 1.76 (m, 2H), 1.50 – 1.38 (m, 4H), 1.36 – 1.27 (m, 
6H); 13C NMR (101 MHz, CDCl3) δ 171.79, 148.71, 140.50, 139.04, 136.28, 134.14, 128.93, 128.13, 
127.87, 127.36, 126.98, 122.59, 121.96, 121.74, 116.64, 83.58, 58.84, 51.90, 39.74, 33.11, 29.49, 
29.43, 29.20, 25.69, 25.04; HRMS (ESI) m/z: 505.2734 (M+); calc. for C33H35N3O2: 505.2729. 
(S)-8-(1,3-Dioxoisoindolin-2-yl)-2-methoxy-N-(quinolin-8-yl)octanamide (3p) 
O
O
N
O
O
HN
N
 
The title compound was prepared according to the GP. The crude product was purified by silica gel 
column chromatography in 5:4:1 petroleum ether: dichloromethane: ethyl acetate, providing 3p as a 
white solid (53.6 mg, 60%). 1H NMR (400 MHz, CDCl3) δ 10.76 (s, 1H), 8.83 (dd, J = 4.1, 1.6 Hz, 
1H), 8.78 (dd, J = 6.5, 2.4 Hz, 1H), 8.12 (dd, J = 8.3, 1.5 Hz, 1H), 7.80 (dd, J = 5.4, 3.0 Hz, 2H), 
7.66 (dd, J = 5.4, 3.0 Hz, 2H), 7.56 – 7.46 (m, 2H), 7.42 (dd, J = 8.2, 4.2 Hz, 1H), 3.82 (dd, J = 7.1, 
4.5 Hz, 1H), 3.64 (t, J = 7.2 Hz, 2H), 3.55 (s, 3H), 1.94 – 1.77 (m, 2H), 1.70 – 1.59 (m, 2H), 1.54 – 
1.43 (m, 2H), 1.41 – 1.29 (m, 4H); 13C NMR (101 MHz, CDCl3) δ 171.70, 168.48, 148.66, 138.98, 
136.21, 134.08, 133.88, 132.23, 128.07, 127.30, 123.20, 121.91, 121.68, 116.60, 83.48, 58.80, 38.04, 
33.05, 29.13, 28.61, 26.82, 25.04; HRMS (EI) m/z: 445.2004 (M+); calc. for C26H27N3O4: 445.2002. 
(S)-N9,2-Dimethoxy-N9-methyl-N1-(quinolin-8-yl)nonanediamide (3q) 
 
The title compound was prepared according to the GP. The crude product was purified by silica gel 
column chromatography in 3:1 petroleum ether: acetone, providing 3q as a colorless oil (41.5 mg, 
53%). 1H NMR (400 MHz, CDCl3) δ 10.77 (s, 1H), 8.85 (dd, J = 4.1, 1.5 Hz, 1H), 8.79 (dd, J = 6.4, 
2.4 Hz, 1H), 8.14 (dd, J = 8.3, 1.5 Hz, 1H), 7.59 – 7.48 (m, 2H), 7.44 (dd, J = 8.3, 4.2 Hz, 1H), 3.83 
(dd, J = 7.2, 4.4 Hz, 1H), 3.65 (s, 3H), 3.56 (s, 3H), 3.15 (s, 3H), 2.38 (t, J = 7.4 Hz, 2H), 1.96 – 
1.78 (m, 2H), 1.68 – 1.56 (m, 2H), 1.50 (dt, J = 14.6, 7.3 Hz, 2H), 1.40 – 1.29 (m, 4H); 13C NMR 
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(101 MHz, CDCl3) δ 174.68, 171.69, 148.59, 138.93, 136.15, 134.03, 128.01, 127.23, 121.83, 
121.61, 116.51, 83.47, 61.18, 58.73, 33.03, 32.20, 31.83, 29.26, 29.22, 24.93, 24.56; HRMS (EI) m/z: 
387.2158 (M+); calc. for C21H29N3O4: 387.2158. 
(2S,6R)-2-Methoxy-6,10-dimethyl-N-(quinolin-8-yl)undec-9-enamide (3r) 
 
The compound 3r was prepared according to the GP and purified by column chromatography in 
petroleum ether: dichloromethane: ethyl acetate = 15:2:1. 3r was obtained as a colorless oil (30.5 mg, 
41%). 1H NMR (400 MHz, CDCl3) δ 10.78 (s, 1H), 8.85 (dd, J = 4.1, 1.5 Hz, 1H), 8.81 (dd, J = 6.7, 
2.0 Hz, 1H), 8.15 (dd, J = 8.2, 1.3 Hz, 1H), 7.60 – 7.47 (m, 2H), 7.45 (dd, J = 8.2, 4.2 Hz, 1H), 5.07 (t, 
J = 6.3 Hz, 1H), 3.84 (dd, J = 7.2, 4.4 Hz, 1H), 3.58 (s, 3H), 2.06 – 1.74 (m, 4H), 1.66 (s, 3H), 1.58 (s, 
3H), 1.54 – 1.47 (m, 1H), 1.46 – 1.37 (m, 2H), 1.36 – 1.28 (m, 2H), 1.20 – 1.08 (m, 2H), 0.86 (d, J = 
6.4 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 171.88, 148.70, 139.06, 136.28, 134.18, 131.10, 128.14, 
127.38, 125.11, 121.94, 121.72, 116.67, 83.74, 58.88, 37.17, 36.90, 33.61, 32.45, 25.83, 25.66, 22.76, 
19.67, 17.74; HRMS (EI) m/z: 368.2466 (M+); calc. for C23H32N2O2: 368.2464. 
(S)-2-Methoxy-N-(quinolin-8-yl)-10-(triisopropylsilyl)dec-9-ynamide (3s) 
 
The compound 3s was prepared according to the GP and purified by column chromatography in 
petroleum ether: dichloromethane: ethyl acetate = 15:2:1. 3s was obtained as a colorless oil (43.0 mg, 
45%). [α]D20 = -39.7(CHCl3, c = 0.95). 1H NMR (400 MHz, CDCl3) δ 10.78 (s, 1H), 8.85 (dd, J = 
4.1, 1.5 Hz, 1H), 8.81 (dd, J = 6.7, 2.0 Hz, 1H), 8.15 (dd, J = 8.3, 1.5 Hz, 1H), 7.62 – 7.49 (m, 2H), 
7.44 (dd, J = 8.2, 4.2 Hz, 1H), 3.84 (dd, J = 7.2, 4.4 Hz, 1H), 3.57 (s, 3H), 2.22 (t, J = 6.7 Hz, 2H), 
1.98 – 1.78 (m, 2H), 1.58 – 1.46 (m, 4H), 1.46 – 1.33 (m, 4H), 1.11 – 0.92 (m, 21H); 13C NMR (101 
MHz, CDCl3) δ 171.79, 148.68, 139.05, 136.26, 134.16, 128.13, 127.37, 121.93, 121.71, 116.65, 
109.32, 83.65, 80.14, 58.84, 33.20, 29.04, 28.88, 28.65, 25.12, 19.90, 18.74, 11.41; HRMS (EI) m/z: 
480.3171 (M+); calc. for C29H44N2O2Si: 480.3172. 
(S)-tert-Butyl 4-methoxy-5-oxo-5-(quinolin-8-ylamino)pentanoate (3t) 
 
The compound 3t was prepared according to the GP and purified by column chromatography in 
petroleum ether: dichloromethane: ethyl acetate = 6:3:1. 3t was obtained as a colorless oil (49.1 mg, 
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71% using 2ta as alkylating reagent; 47.2 mg, 68% using 2tb as alkylating reagent). 1H NMR (400 
MHz, CDCl3) δ 10.80 (s, 1H), 8.84 (dd, J = 4.1, 1.6 Hz, 1H), 8.80 (dd, J = 5.9, 2.9 Hz, 1H), 8.14 (dd, 
J = 8.2, 1.4 Hz, 1H), 7.61 – 7.47 (m, 2H), 7.44 (dd, J = 8.2, 4.2 Hz, 1H), 3.91 (dd, J = 6.8, 4.7 Hz, 1H), 
3.57 (s, 3H), 2.51 – 2.35 (m, 2H), 2.30 – 2.21 (m, 1H), 2.19 – 2.08 (m, 1H), 1.43 (s, 9H); 13C NMR 
(101 MHz, CDCl3) δ 172.38, 170.89, 148.69, 139.00, 136.27, 134.01, 128.10, 127.31, 122.06, 121.73, 
116.68, 82.29, 80.40, 58.80, 31.16, 28.17, 28.11; HRMS (EI) m/z: 344.1729 (M+); calc. for 
C19H24N2O4: 344.1736. 
(S)-Ethyl 4-methoxy-5-oxo-5-(quinolin-8-ylamino)pentanoate (3u) 
 
The compound 3u was prepared according to the GP and purified by column chromatography in 
petroleum ether: dichloromethane: ethyl acetate = 5:4:1. 3u was obtained as a colorless oil (32.4 mg, 
51% using 2za as alkylating reagent; 16.0 mg, 25% using 2zb as alkylating reagent). [α]D20 = -58.5  
(CHCl3, c = 1.0). 1H NMR (400 MHz, CDCl3) δ 10.80 (s, 1H), 8.84 (dd, J = 4.1, 1.6 Hz, 1H), 8.79 (dd, 
J = 5.6, 3.3 Hz, 1H), 8.15 (dd, J = 8.3, 1.5 Hz, 1H), 7.62 – 7.48 (m, 2H), 7.45 (dd, J = 8.2, 4.2 Hz, 1H), 
4.12 (qd, J = 7.1, 2.2 Hz, 2H), 3.92 (dd, J = 6.9, 4.7 Hz, 1H), 3.58 (s, 3H), 2.64 – 2.39 (m, 2H), 2.29 
(dtd, J = 12.0, 7.5, 4.8 Hz, 1H), 2.19 (ddd, J = 14.3, 8.5, 6.8 Hz, 1H), 1.23 (t, J = 7.1 Hz, 3H); 13C 
NMR (101 MHz, CDCl3) δ 173.12, 170.77, 148.71, 138.98, 136.29, 133.94, 128.10, 127.31, 122.12, 
121.75, 116.70, 82.18, 60.53, 58.85, 29.97, 28.00, 14.29; HRMS (EI) m/z: 316.1421 (M+); calc. for 
C17H20N2O4: 316.1423. 
(S)-tert-Butyl 4-benzyloxy-5-oxo-5-(quinolin-8-ylamino)pentanoate (3v) 
 
The compound 3v was prepared according to the GP (using 1b and 2tb as substrate) and purified by 
column chromatography in petroleum ether: dichloromethane: ethyl acetate = 6:3:1. 3v was obtained 
as a colorless oil (54.0 mg, 64%). 1H NMR (400 MHz, CDCl3) δ 11.06 (s, 1H), 9.02 – 8.62 (m, 2H), 
8.16 (d, J = 8.2 Hz, 1H), 7.76 – 7.51 (m, 4H), 7.46 (dd, J = 8.2, 4.2 Hz, 1H), 7.44 – 7.27 (m, 3H), 
4.81 (d, J = 11.2 Hz, 1H), 4.65 (d, J = 11.2 Hz, 1H), 4.15 (dd, J = 6.6, 4.8 Hz, 1H), 2.47 (t, J = 7.7 
Hz, 2H), 2.38 – 2.27 (m, 1H), 2.27 – 2.12 (m, 1H), 1.42 (s, 9H); 13C NMR (101 MHz, CDCl3) δ 
172.32, 170.91, 148.50, 138.95, 137.15, 136.27, 134.03, 128.57, 128.47, 128.21, 128.08, 127.34, 
122.05, 121.77, 116.61, 80.43, 79.93, 73.22, 31.23, 28.40, 28.16; HRMS (EI) m/z: 420.2049 (M+); 
calc. for C25H28N2O4: 420.2046. 
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(S)-2-(Benzyloxy)-N-(quinolin-8-yl)-5-((triisopropylsilyl)oxy)pentanamide (3w) 
O HN
O
N
OSi
 
The compound 3w was prepared according to the GP (using 1b and 2u as substrate) and purified by 
column chromatography in petroleum ether: dichloromethane: ethyl acetate = 15:2:1. 3w was 
obtained as a colorless oil (46.8 mg, 46%). 1H NMR (400 MHz, CDCl3) δ 11.05 (s, 1H), 9.02 – 8.63 
(m, 2H), 8.16 (dd, J = 8.2, 1.1 Hz, 1H), 7.69 – 7.50 (m, 4H), 7.45 (dd, J = 8.2, 4.2 Hz, 1H), 7.44 – 
7.27 (m, 3H), 4.82 (d, J = 11.2 Hz, 1H), 4.64 (d, J = 11.2 Hz, 1H), 4.13 (dd, J = 7.2, 4.4 Hz, 1H), 
3.91 – 3.60 (m, 2H), 2.18 – 2.06 (m, 1H), 1.98 (dt, J = 14.0, 7.3 Hz, 1H), 1.86 – 1.75 (m, 2H), 1.22 – 
0.97 (m, 21H); 13C NMR (101 MHz, CDCl3) δ 171.66, 148.50, 139.03, 137.43, 136.25, 134.21, 
128.55, 128.44, 128.13, 127.39, 121.93, 121.75, 116.62, 81.12, 73.11, 63.17, 29.79, 28.75, 18.15, 
12.09; HRMS (EI) m/z: 506.2965 (M+); calc. for C30H42N2O3Si: 506.2966. 
(S)-2-Methoxy-N-3-(methyl-d3)-(quinolin-8-yl)propanamide (3x) 
O HN
O
ND
D
D
 
The compound 3x was prepared according to the GP and purified by column chromatography in 
petroleum ether: dichloromethane: ethyl acetate = 12:2:1. 3x was obtained as a white solid (30.0 mg, 
60%) with 3x’ (15.8 mg, 30%) isolated. 1H NMR (400 MHz, CDCl3) δ 10.79 (s, 1H), 8.85 (dd, J = 4.1, 
1.4 Hz, 1H), 8.81 (dd, J = 6.8, 1.9 Hz, 1H), 8.14 (dd, J = 8.2, 1.3 Hz, 1H), 7.61 – 7.47 (m, 2H), 7.44 (dd, 
J = 8.2, 4.2 Hz, 1H), 3.82 (dd, J = 6.6, 4.7 Hz, 1H), 3.58 (s, 3H), 1.96 (dd, J = 13.9, 3.6 Hz, 1H), 1.87 
(dd, J = 14.1, 6.6 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 171.63, 148.69, 139.04, 136.27, 134.14, 
128.13, 127.35, 121.94, 121.71, 116.64, 84.43, 58.72, 25.83; HRMS (EI) m/z: 247.1403 (M+); calc. 
for C14H13D3N2O2: 247.1400. 
(S)-2-Methoxy-N-3,3-di(methyl-d3)-(quinolin-8-yl)propanamide (3x’) 
 
1H NMR (400 MHz, CDCl3) δ 10.75 (s, 1H), 8.85 (dd, J = 4.1, 1.5 Hz, 1H), 8.82 (dd, J = 6.8, 2.0 Hz, 
1H), 8.15 (dd, J = 8.3, 1.5 Hz, 1H), 7.61 – 7.49 (m, 2H), 7.45 (dd, J = 8.2, 4.2 Hz, 1H), 3.63 (d, J = 4.5 
Hz, 1H), 3.59 (s, 3H), 2.21 (d, J = 4.5 Hz 1H); 13C NMR (101 MHz, CDCl3) δ 171.40, 148.73, 139.09, 
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136.27, 134.12, 128.16, 127.39, 121.91, 121.73, 116.63, 88.62, 59.81, 31.66; HRMS (EI) m/z: 
264.1746 (M+); calc. for C15H12D6N2O2: 264.1745. 
(S)-2-Methoxy-N-3-(ethyl-d5)-(quinolin-8-yl)propanamide (3y) 
 
The compound 3y was prepared according to the GP and purified by column chromatography in 
petroleum ether: dichloromethane: ethyl acetate = 12:2:1. 3y was obtained as a colorless oil (35.5 mg, 
67%). 1H NMR (400 MHz, CDCl3) δ 10.79 (s, 1H), 8.85 (dd, J = 4.1, 1.6 Hz, 1H), 8.81 (dd, J = 6.8, 1.9 
Hz, 1H), 8.14 (dd, J = 8.3, 1.5 Hz, 1H), 7.62 – 7.48 (m, 2H), 7.44 (dd, J = 8.2, 4.2 Hz, 1H), 3.86 (dd, J 
= 7.2, 4.6 Hz, 1H), 3.58 (s, 3H), 1.85 (qd, J = 14.0, 5.7 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ 171.89, 
148.68, 139.02, 136.26, 134.15, 128.11, 127.34, 121.92, 121.70, 116.61, 83.46, 58.82, 35.02; HRMS 
(EI) m/z: 263.1681 (M+); calc. for C15H13D5N2O2: 263.1682. 
(S)-2-Methoxy-N-(quinolin-8-yl)-8-(((3aR,5R,5aS,8aS,8bR)-2,2,7,7-tetramethyltetrahydro-3aH-
bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-5-yl)methoxy)octanamide (3z) 
 
The compound 3z was prepared according to the GP and purified by column chromatography in 
petroleum ether: dichloromethane: ethyl acetate = 5:4:1. 3z was obtained as a white solid (69.5 mg, 
62%). 1H NMR (400 MHz, CDCl3) δ 10.77 (s, 1H), 8.85 (dd, J = 4.1, 1.6 Hz, 1H), 8.80 (dd, J = 6.5, 
2.3 Hz, 1H), 8.15 (dd, J = 8.3, 1.6 Hz, 1H), 7.59 – 7.47 (m, 2H), 7.45 (dd, J = 8.2, 4.2 Hz, 1H), 5.52 (d, 
J = 5.0 Hz, 1H), 4.58 (dd, J = 7.9, 2.2 Hz, 1H), 4.28 (dd, J = 5.0, 2.3 Hz, 1H), 4.24 (dd, J = 7.9, 1.7 Hz, 
1H), 3.93 (dd, J = 8.5, 3.7 Hz, 1H), 3.83 (dd, J = 7.2, 4.4 Hz, 1H), 3.65 – 3.50 (m, 5H), 3.49 – 3.39 (m, 
2H), 1.98 – 1.78 (m, 2H), 1.62 – 1.45 (m, 7H), 1.43 (s, 3H), 1.37 – 1.28 (m, 10H); 13C NMR (101 MHz, 
CDCl3) δ 171.83, 148.71, 139.06, 136.28, 134.17, 128.14, 127.38, 121.94, 121.73, 116.65, 109.29, 
108.62, 96.50, 83.64, 71.61, 71.32, 70.77, 69.42, 66.83, 58.85, 33.19, 29.65, 29.42, 26.22, 26.11, 
26.05, 25.17, 25.06, 24.56; HRMS (EI) m/z: 558.2943 (M+); calc. for C30H42N2O8: 558.2941. 
(S)-Methyl 4-methoxy-5-oxo-5-(quinolin-8-ylamino)pentanoate (3aa) 
 
The compound 3aa was prepared according to the GP and purified by column chromatography in 
petroleum ether: dichloromethane: ethyl acetate = 5:4:1. 3aa was obtained as a colorless oil (27.0 mg, 
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45% using 2ya as alkylating reagent; 12.2 mg, 20% using 2yb as alkylating reagent). 1H NMR (400 
MHz, CDCl3) δ 10.79 (s, 1H), 8.85 (dd, J = 4.0, 1.4 Hz, 1H), 8.79 (dd, J = 5.1, 3.5 Hz, 1H), 8.16 (dd, 
J = 8.2, 1.5 Hz, 1H), 7.60 – 7.49 (m, 2H), 7.46 (dd, J = 8.1, 4.1 Hz, 1H), 3.92 (dd, J = 6.6, 4.8 Hz, 1H), 
3.67 (s, 3H), 3.58 (s, 3H), 2.62 – 2.44 (m, 2H), 2.36 – 2.14 (m, 2H); 13C NMR (101 MHz, CDCl3) δ 
173.58, 170.73, 148.73, 138.99, 136.30, 133.94, 128.11, 127.32, 122.14, 121.76, 116.72, 82.14, 58.87, 
51.76, 29.72, 28.00; HRMS (EI) m/z: 302.1266 (M+); calc. for C16H18N2O4: 302.1267. 
(S)-Benzyl 4-methoxy-5-oxo-5-(quinolin-8-ylamino)pentanoate (3ab) 
 
The compound 3ab was prepared according to the GP and purified by column chromatography in 
petroleum ether: dichloromethane: ethyl acetate = 5:4:1. 3ab was obtained as a colorless oil (21.4 
mg, 28% using 2aaa as alkylating reagent; 11.5 mg, 15% using 2aab as alkylating reagent). 1H 
NMR (400 MHz, CDCl3) δ 10.81 (s, 1H), 8.84 (dd, J = 4.2, 1.5 Hz, 1H), 8.80 (dd, J = 5.3, 3.6 Hz, 1H), 
8.16 (dd, J = 8.2, 1.3 Hz, 1H), 7.61 – 7.48 (m, 2H), 7.45 (dd, J = 8.2, 4.2 Hz, 1H), 7.41 – 7.25 (m, 5H), 
5.25 – 4.97 (m, 2H), 3.93 (dd, J = 6.8, 4.8 Hz, 1H), 3.55 (s, 3H), 2.71 – 2.44 (m, 2H), 2.33 (dt, J = 12.0, 
7.5 Hz, 1H), 2.23 (dt, J = 14.3, 6.8 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 172.96, 170.72, 148.74, 
139.00, 136.31, 136.06, 133.95, 128.64, 128.33, 128.29, 128.12, 127.34, 122.16, 121.77, 116.74, 
82.14, 66.43, 58.86, 29.97, 27.94; HRMS (EI) m/z: 378.1584 (M+); calc. for C22H22N2O4: 378.1580. 
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Removal of 8-AQ Auxiliary 
 
tert-Butyl (S)-(2-methoxyheptanoyl)(quinolin-8-yl)carbamate (5a) 
O
N
O
NOO
 
To a solution of 3a (114.6 mg, 0.4 mmol) in dry MeCN (4 mL) were added di-tert-butyl dicarbonate 
(Boc2O, 261.9 mg, 1.2 mmol) and N,N-dimethylpyridin-4-amine (DMAP, 97.7 mg, 0.8 mmol). The 
mixture was stirred at room temperature for 4 hours. Then the reaction was diluted with 
dichloromethane (15 mL), washed by water (15 mL), brine (20 mL), and dried over anhydrous 
MgSO4. Evaporation of organic solvent and purification by column chromatography in petroleum 
ether: ethyl acetate = 2:1 gave the product 5a as a yellow solid (101.1 mg, 65%). 1H NMR (400 MHz, 
Chloroform-d) δ 8.86 (dd, J = 4.1, 1.6 Hz, 1H), 8.16 (dd, J = 8.3, 1.6 Hz, 1H), 7.81 (dd, J = 8.0, 1.3 Hz, 
1H), 7.55 (t, J = 7.7 Hz, 1H), 7.50 (dd, J = 7.3, 1.4 Hz, 1H), 7.40 (dd, J = 8.3, 4.2 Hz, 1H), 5.05 (dd, J 
= 8.0, 3.3 Hz, 1H), 3.45 (s, 3H), 2.02 (dq, J = 10.1, 3.3, 2.9 Hz, 1H), 1.87 – 1.77 (m, 1H), 1.62 – 1.51 
(m, 2H), 1.40 – 1.32 (m, 4H), 1.23 (s, 9H), 0.91 (t, J = 6.8 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 
176.35, 152.79, 150.29, 144.16, 136.68, 135.91, 128.88, 128.07, 126.04, 121.50, 82.77, 81.52, 77.35, 
77.03, 76.71, 57.96, 33.15, 31.73, 27.59, 25.33, 22.56, 14.09. 
(S)-2-Methoxyheptanoic acid (4a) 
 
To a solution of 5a (38.7 mg, 0.1 mmol) in THF/H2O (3:1, 0.5 mL) were added LiOH (4.8 mg, 0.2 
mmol) and H2O2 (30%, 50 μL, 0.5 mmol). The mixture was stirred at room temperature for 4 hours. 
Then the reaction was acidified by HCl (0.5 M, 12 mL), diluted with ethyl acetate (15 mL), washed by 
water (15 mL), brine (20 mL), and dried over anhydrous MgSO4. Evaporation of organic solvent and 
purification by column chromatography in petroleum ether: ethyl acetate = 1:1 gave the product 4a as 
a light yellow oil (15.4 mg, 96%) with 4b (24.0 mg, 98%) isolated. 1H NMR (400 MHz, 
Chloroform-d) δ 3.80 (dd, J = 6.7, 5.1 Hz, 1H), 3.44 (s, 3H), 1.89 – 1.68 (m, 2H), 1.42 (p, J = 7.4 Hz, 
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2H), 1.35 – 1.27 (m, 4H), 0.89 (t, J = 6.9 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 176.47, 80.23, 77.33, 
77.02, 76.70, 58.29, 32.20, 31.46, 24.49, 22.43, 13.96. 
tert-Butyl quinolin-8-ylcarbamate (4b) 
NH
N
O
O
 
1H NMR (400 MHz, CDCl3) δ 9.02 (s, 1H), 8.79 (dd, J = 4.1, 1.5 Hz, 1H), 8.42 (d, J = 7.4 Hz, 1H), 
8.13 (dd, J = 8.2, 1.4 Hz, 1H), 7.51 (t, J = 8.0 Hz, 1H), 7.46 – 7.35 (m, 2H), 1.58 (s, 9H); 13C NMR 
(101 MHz, CDCl3) δ 153.05, 148.09, 138.41, 136.37, 135.35, 128.21, 127.49, 121.63, 120.28, 
114.59, 80.54, 28.55; HRMS (EI) m/z: 244.1210 (M+); calc. for C14H16N2O2: 244.1212. 
 
 - 24 -
References 
1. Barrett, A. G. M.; Braddock, D. C.; Christian, P. W. N.; Pilipauskas, D.; White, A. J. P.; Williams, 
D. J. Journal of Organic Chemistry, 1998, 63, 5818 – 5823. 
 - 25 -
 
 
 - 26 -
 
 - 27 -
 
 
 - 28 -
 
 
 - 29 -
 
 
 - 30 -
 
 
 - 31 -
 
 
 - 32 -
 
 
 - 33 -
 
 
 - 34 -
 
 
 - 35 -
 
 
 - 36 -
 
 
 - 37 -
 
 
 - 38 -
 
 
 - 39 -
 
 
 - 40 -
 
 
 - 41 -
 
 
 - 42 -
 
 
 - 43 -
 
 
 - 44 -
 
 
 - 45 -
 
 
 - 46 -
 
 
 - 47 -
 
 
 - 48 -
 
 
 - 49 -
 
 
 - 50 -
 
 - 51 -
 
 
 - 52 -
 
 
 - 53 -
 
 
 - 54 -
 
 
 - 55 -
 
 
 - 56 -
 
 
 - 57 -
 
 
 - 58 -
 
 
 - 59 -
 
